122 related articles for article (PubMed ID: 28404689)
1. Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells.
Patel AB; Theoharides TC
J Pharmacol Exp Ther; 2017 Jun; 361(3):462-471. PubMed ID: 28404689
[TBL] [Abstract][Full Text] [Related]
2. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin.
Bawazeer MA; Theoharides TC
Eur J Pharmacol; 2019 Dec; 865():172760. PubMed ID: 31669588
[TBL] [Abstract][Full Text] [Related]
3. The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.
Weng Z; Patel AB; Panagiotidou S; Theoharides TC
J Allergy Clin Immunol; 2015 Apr; 135(4):1044-1052.e5. PubMed ID: 25498791
[TBL] [Abstract][Full Text] [Related]
4. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.
Taracanova A; Alevizos M; Karagkouni A; Weng Z; Norwitz E; Conti P; Leeman SE; Theoharides TC
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4002-E4009. PubMed ID: 28461492
[TBL] [Abstract][Full Text] [Related]
5. Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.
Taracanova A; Tsilioni I; Conti P; Norwitz ER; Leeman SE; Theoharides TC
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9381-E9390. PubMed ID: 30232261
[TBL] [Abstract][Full Text] [Related]
6. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.
Kempuraj D; Tagen M; Iliopoulou BP; Clemons A; Vasiadi M; Boucher W; House M; Wolfberg A; Theoharides TC
Br J Pharmacol; 2008 Dec; 155(7):1076-84. PubMed ID: 18806808
[TBL] [Abstract][Full Text] [Related]
7. The effects of P. gingivalis and E. coli LPS on the expression of proinflammatory mediators in human mast cells and their relevance to periodontal disease.
Palaska I; Gagari E; Theoharides TC
J Biol Regul Homeost Agents; 2016; 30(3):655-664. PubMed ID: 27655482
[TBL] [Abstract][Full Text] [Related]
8. TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin.
Patel AB; Tsilioni I; Weng Z; Theoharides TC
Exp Dermatol; 2018 Feb; 27(2):135-143. PubMed ID: 29105195
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.
Patel AB; Tsilioni I; Leeman SE; Theoharides TC
Proc Natl Acad Sci U S A; 2016 Nov; 113(45):E7049-E7058. PubMed ID: 27663735
[TBL] [Abstract][Full Text] [Related]
10. Mercury induces inflammatory mediator release from human mast cells.
Kempuraj D; Asadi S; Zhang B; Manola A; Hogan J; Peterson E; Theoharides TC
J Neuroinflammation; 2010 Mar; 7():20. PubMed ID: 20222982
[TBL] [Abstract][Full Text] [Related]
11. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
12. Luteolin and thiosalicylate inhibit HgCl(2) and thimerosal-induced VEGF release from human mast cells.
Asadi S; Zhang B; Weng Z; Angelidou A; Kempuraj D; Alysandratos KD; Theoharides TC
Int J Immunopathol Pharmacol; 2010; 23(4):1015-20. PubMed ID: 21244751
[TBL] [Abstract][Full Text] [Related]
13. Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines.
Lauritano D; Mastrangelo F; D'Ovidio C; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Trimarchi M; Carinci F; Conti P
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902240
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.
Fan W; Cheng K; Qin X; Narsinh KH; Wang S; Hu S; Wang Y; Chen Y; Wu JC; Xiong L; Cao F
Stem Cells; 2013 Jan; 31(1):203-14. PubMed ID: 23081858
[TBL] [Abstract][Full Text] [Related]
15. Brefeldin A reduces tumor necrosis factor-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR, and NF-κB pathways in human keratinocytes.
Nam YJ; Lee CS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):951-60. PubMed ID: 27198515
[TBL] [Abstract][Full Text] [Related]
16. Luteolin inhibits mast cell-mediated allergic inflammation.
Kritas SK; Saggini A; Varvara G; Murmura G; Caraffa A; Antinolfi P; Toniato E; Pantalone A; Neri G; Frydas S; Rosati M; Tei M; Speziali A; Saggini R; Pandolfi F; Cerulli G; Theoharides TC; Conti P
J Biol Regul Homeost Agents; 2013; 27(4):955-9. PubMed ID: 24382176
[TBL] [Abstract][Full Text] [Related]
17. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.
Perl A
Nat Rev Rheumatol; 2016 Mar; 12(3):169-82. PubMed ID: 26698023
[TBL] [Abstract][Full Text] [Related]
18. PI3K/mTOR signaling pathways in medulloblastoma.
Mohan AL; Friedman MD; Ormond DR; Tobias M; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2012 Aug; 32(8):3141-6. PubMed ID: 22843885
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin.
Asadi S; Theoharides TC
J Neuroinflammation; 2012 May; 9():85. PubMed ID: 22559745
[TBL] [Abstract][Full Text] [Related]
20. The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis.
Okamura Y; Mishima S; Kashiwakura JI; Sasaki-Sakamoto T; Toyoshima S; Kuroda K; Saito S; Tokuhashi Y; Okayama Y
Allergol Int; 2017 Sep; 66S():S9-S20. PubMed ID: 28366675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
